Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1993;24:1049-1053

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, Y.
Right arrow Articles by Shibuya, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, Y.
Right arrow Articles by Shibuya, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-ARGININE
*NITRIC OXIDE
*VASOPRESSIN

Stroke, Vol 24, 1049-1053, Copyright © 1993 by American Heart Association


ARTICLES

Regional differences in the vasodilator response to vasopressin in canine cerebral arteries in vivo

Y Suzuki, S Satoh, H Oyama, M Takayasu and M Shibuya
Department of Neurosurgery, Nagoya University School of Medicine, Japan.

BACKGROUND AND PURPOSE: The aim of this study was to investigate the regional differences in the in vivo vasodilator responses to vasopressin, which is thought to stimulate the release of nitric oxide from the endothelium, in canine cerebral arteries by angiography. METHODS: Angiograms were performed through a catheter inserted directly into the right vertebral artery and were taken periodically after the infusion of vasopressin. The diameters of various segments of the major arteries were measured using a computerized image analysis system. RESULTS: The bolus administration of vasopressin (10 pmol to 1 nmol) into the vertebral artery produced a long-lasting, dose-dependent vasodilation in the major cerebral arteries centering around the circle of Willis. One nanomole of vasopressin appeared to be the optimal dose for producing maximal vasodilation. The internal diameters of the basilar, posterior communicating, and internal carotid arteries experienced the most dilation (approximately 150% that of control) 2 minutes after the infusion of 1 nmol of vasopressin, followed by those of the middle cerebral, the intracranial portion of the vertebral, and the anterior spinal arteries (approximately 130% that of control). The extracranial portion of the vertebral artery (109.8 +/- 4.8% that of control, n = 4) was less sensitive to 1 nmol of vasopressin. Pretreatment with an intracisternal injection of 10 mumol of NG- monomethyl L-arginine suppressed the vasodilator effect of vasopressin and substance P, whereas it did not affect the response to vasoactive intestinal peptide. CONCLUSIONS: These results suggest that the arteries composing the circle of Willis at the base of the brain are more sensitive to nitric oxide release induced by vasopressin compared with other intracranial and extracranial arteries.


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. Jeon, J. H. Ryu, Y. J. Lim, C. S. Kim, J.-H. Bahk, S. Z. Yoon, and J. Y. Choi
Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients.
Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 952 - 956.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C.-C. Yeh, C.-T. Wu, C.-H. Lu, C.-P. Yang, and C.-S. Wong
Early Use of Small-Dose Vasopressin for Unstable Hemodynamics in an Acute Brain Injury Patient Refractory to Catecholamine Treatment: A Case Report
Anesth. Analg., August 1, 2003; 97(2): 577 - 579.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda and T. Okamura
The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels
Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. L. Holmes, B. M. Patel, J. A. Russell, and K. R. Walley
Physiology of Vasopressin Relevant to Management of Septic Shock
Chest, September 1, 2001; 120(3): 989 - 1002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. Balsam and N. Nikbakht
L-Arginine inhibits vasopressin-stimulated mesangial cell Ca2+
Am J Physiol Cell Physiol, August 1, 1998; 275(2): C352 - C357.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. M. FARACI and D. D. HEISTAD
Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels
Physiol Rev, January 1, 1998; 78(1): 53 - 97.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. W. Prengel, K. H. Lindner, A. Keller, and R. C. Koehler
Cerebral Oxygenation During Cardiopulmonary Resuscitation With Epinephrine and Vasopressin in Pigs
Stroke, July 1, 1996; 27(7): 1241 - 1248.
[Abstract] [Full Text]


Home page
CirculationHome page
K. H. Lindner, A. W. Prengel, E. G. Pfenninger, I. M. Lindner, H.-U. Strohmenger, M. Georgieff, and K. G. Lurie
Vasopressin Improves Vital Organ Blood Flow During Closed-Chest Cardiopulmonary Resuscitation in Pigs
Circulation, January 1, 1995; 91(1): 215 - 221.
[Abstract] [Full Text]